日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/07/11 | 1,500 | 1,510 | 1,491 | 1,500 | -3 | -0.2% | 7,400 |
| 2025/07/10 | 1,493 | 1,503 | 1,491 | 1,503 | +8 | +0.5% | 400 |
| 2025/07/09 | 1,504 | 1,504 | 1,486 | 1,495 | -9 | -0.6% | 1,500 |
| 2025/07/08 | 1,506 | 1,508 | 1,496 | 1,504 | +8 | +0.5% | 4,500 |
| 2025/07/07 | 1,505 | 1,505 | 1,496 | 1,496 | -20 | -1.3% | 700 |
| 2025/07/04 | 1,490 | 1,516 | 1,490 | 1,516 | +26 | +1.7% | 1,000 |
| 2025/07/03 | 1,506 | 1,506 | 1,490 | 1,490 | -16 | -1.1% | 800 |
| 2025/07/02 | 1,480 | 1,506 | 1,471 | 1,506 | +36 | +2.4% | 3,400 |
| 2025/07/01 | 1,470 | 1,472 | 1,470 | 1,470 | -11 | -0.7% | 900 |
| 2025/06/30 | 1,508 | 1,508 | 1,481 | 1,481 | -27 | -1.8% | 900 |
| 2025/06/27 | 1,470 | 1,508 | 1,470 | 1,508 | +34 | +2.3% | 1,900 |
| 2025/06/26 | 1,491 | 1,503 | 1,474 | 1,474 | -17 | -1.1% | 2,800 |
| 2025/06/25 | 1,494 | 1,502 | 1,491 | 1,491 | -3 | -0.2% | 1,600 |
| 2025/06/24 | 1,518 | 1,518 | 1,494 | 1,494 | -25 | -1.6% | 3,400 |
| 2025/06/23 | 1,495 | 1,519 | 1,495 | 1,519 | +20 | +1.3% | 600 |
| 2025/06/20 | 1,498 | 1,504 | 1,497 | 1,499 | +19 | +1.3% | 4,000 |
| 2025/06/19 | 1,471 | 1,480 | 1,470 | 1,480 | +10 | +0.7% | 400 |
| 2025/06/18 | 1,469 | 1,470 | 1,469 | 1,470 | -10 | -0.7% | 1,300 |
| 2025/06/17 | 1,480 | 1,480 | 1,475 | 1,480 | ±0 | ±0% | 600 |
| 2025/06/16 | 1,480 | 1,480 | 1,477 | 1,480 | +4 | +0.3% | 600 |
| 2025/06/13 | 1,476 | 1,476 | 1,476 | 1,476 | - | - | 300 |
| 2025/06/12 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2025/06/11 | 1,477 | 1,477 | 1,477 | 1,477 | -3 | -0.2% | 200 |
| 2025/06/10 | 1,480 | 1,480 | 1,480 | 1,480 | ±0 | ±0% | 3,600 |
| 2025/06/09 | 1,480 | 1,480 | 1,480 | 1,480 | +2 | +0.1% | 2,000 |
| 2025/06/06 | 1,477 | 1,479 | 1,462 | 1,478 | +17 | +1.2% | 2,700 |
| 2025/06/05 | 1,470 | 1,470 | 1,460 | 1,461 | -9 | -0.6% | 2,400 |
| 2025/06/04 | 1,475 | 1,479 | 1,470 | 1,470 | -5 | -0.3% | 8,300 |
| 2025/06/03 | 1,475 | 1,475 | 1,475 | 1,475 | +1 | +0.1% | 200 |
| 2025/06/02 | 1,471 | 1,484 | 1,471 | 1,474 | +3 | +0.2% | 1,200 |
| 2025/05/30 | 1,482 | 1,484 | 1,457 | 1,471 | -9 | -0.6% | 1,300 |
| 2025/05/29 | 1,465 | 1,480 | 1,465 | 1,480 | -9 | -0.6% | 800 |
| 2025/05/28 | 1,480 | 1,489 | 1,462 | 1,489 | +9 | +0.6% | 500 |
| 2025/05/27 | 1,471 | 1,488 | 1,448 | 1,480 | ±0 | ±0% | 2,800 |
| 2025/05/26 | 1,488 | 1,491 | 1,471 | 1,480 | -5 | -0.3% | 11,700 |
| 2025/05/23 | 1,470 | 1,485 | 1,470 | 1,485 | +35 | +2.4% | 1,600 |
| 2025/05/22 | 1,461 | 1,462 | 1,450 | 1,450 | -11 | -0.8% | 1,400 |
| 2025/05/21 | 1,465 | 1,465 | 1,448 | 1,461 | -3 | -0.2% | 3,400 |
| 2025/05/20 | 1,459 | 1,464 | 1,452 | 1,464 | +5 | +0.3% | 1,200 |
| 2025/05/19 | 1,458 | 1,461 | 1,458 | 1,459 | +2 | +0.1% | 700 |
| 2025/05/16 | 1,477 | 1,482 | 1,457 | 1,457 | -20 | -1.4% | 1,500 |
| 2025/05/15 | 1,520 | 1,520 | 1,460 | 1,477 | -53 | -3.5% | 5,400 |
| 2025/05/14 | 1,518 | 1,534 | 1,518 | 1,530 | +14 | +0.9% | 3,200 |
| 2025/05/13 | 1,500 | 1,543 | 1,500 | 1,516 | -13 | -0.9% | 2,000 |
| 2025/05/12 | 1,531 | 1,531 | 1,490 | 1,529 | -1 | -0.1% | 1,800 |
| 2025/05/09 | 1,485 | 1,530 | 1,480 | 1,530 | +41 | +2.8% | 5,700 |
| 2025/05/08 | 1,479 | 1,510 | 1,478 | 1,489 | +10 | +0.7% | 4,900 |
| 2025/05/07 | 1,460 | 1,485 | 1,460 | 1,479 | +24 | +1.6% | 1,400 |
| 2025/05/02 | 1,452 | 1,455 | 1,452 | 1,455 | +3 | +0.2% | 300 |
| 2025/05/01 | 1,493 | 1,493 | 1,452 | 1,452 | -13 | -0.9% | 1,800 |
1～
50
件表示中 / 3740件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 150,000円 | +7.5% | -77.4% | 3.33% | 36.08倍 | 0.28倍 |
|
後発薬中堅、検査薬事業が第２の柱に。提携含めた新薬開発、ベトナムなど海外事業を中期強化 |
| モダリス | 9,400円 | - | - | 0.00% | - | 2.05倍 |
|
遺伝子治療薬の創薬ベンチャー、ＤＮＡ切断しないエピゲノム編集に強み。研究開発中心は米国 |
| カルナバイオ | 34,800円 | +13.5% | - | 0.00% | - | 2.69倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＤＷＴＩ | 13,700円 | -15.1% | - | 0.00% | - | 8.56倍 |
|
三重大学発創薬ベンチャー。プロテインキナーゼ阻害剤開発技術はじめ眼病治療薬開発に集中 |
| ペルセウス | 41,400円 | +25.0% | - | 0.00% | - | 4.51倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体（ＡＤＣ）開発 |
市場注目の銘柄
チャート関連のコラム
